Description
The GE Discovery IQ Gen 2 PET/CT System builds upon GE’s high-efficiency molecular imaging platform to deliver enhanced image clarity, quantitative accuracy, and operational efficiency. Designed with a digital-ready detector platform and automated workflow capabilities, the Gen 2 system empowers clinicians to detect tiny lesions sooner, track treatment progress with confidence, and optimize daily throughput while keeping radiation doses as low as reasonably achievable.
Key Features
-
Enhanced LightGuide Detector Platform: Delivers high sensitivity and high count-rate capability across multi-ring configurations for fast, detailed imaging.
-
Q.Clear Quantitative Reconstruction: Delivers up to 2x improvement in both image quality (SNR) and quantitative SUV accuracy for confident therapy monitoring.
-
Auto-Positioning & Smart Workflow: Camera-assisted auto-positioning simplifies patient setup, speeds up exam start times, and reduces operator error.
-
Low-Dose CT & Reduced Tracer Needs: Allows high-clarity scans using lower radiotracer injection doses and low-dose CT protocols.
-
Motion Management Integration: Advanced respiratory gating and motion reduction tools ensure high image sharpness in chest and abdominal regions.
Key Benefits
-
High-Precision Small Lesion Detection: Superior spatial resolution and SNR enable clinicians to identify subtle primary tumors and metastases early.
-
Reliable Quantitative Accuracy: SUV measurements remain consistent across exams, ensuring accurate evaluation of response to cancer therapies over time.
-
Streamlined Clinical Efficiency: Smart auto-positioning and fast scanning reduce patient setup time and increase overall daily room turnover.
-
Patient-Centered Radiation Safety: Reduced required radiotracer doses minimize overall radiation exposure for patients without sacrificing diagnostic image quality.
-
Scalable Investment: Designed with a modular architecture that adapts as clinical volume and imaging demands grow over time.
Reviews
There are no reviews yet.